1338. Deputy Duncan Smith asked the Minister for Health with reference to the framework agreement on the supply and pricing of medicines 2026-2029's commitment to develop an early access scheme for rare diseases; if she will consider the equity of creating a fast-track for patients with rare diseases versus the track for patients whose diseases may not be rare but may have a greater clinical need; if she will consider the appropriateness of creating a two-speed system considering Section 21-2-D of the Health (Pricing & Supply of Medical Goods) Act 2013; if she agrees that an early access scheme should be an accelerator for patients whose medical needs are most urgent; if she will confirm that the principle of equity will be upheld in the planned early access scheme; and if she will make a statement on the matter. [39350/26]

Summary

1338. Deputy Duncan Smith asked the Minister for Health with reference to the framework agreement on the supply and pricing of medicines 2026-2029's commitment to develop an early access scheme for rare diseases; if she will consider the equity of creating a fast-track for patients with rare diseases versus the track for patients whose diseases may not be rare but may have a greater clinical need; if she will consider the appropriateness of creating a two-speed system considering Section 21-2-D of the Health (Pricing & Supply of Medical Goods) Act 2013; if she agrees that an early access scheme should be an accelerator for patients whose medical needs are most urgent; if she will confirm that the principle of equity will be upheld in the planned early access scheme; and if she will make a statement on the matter. [39350/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 26 May 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.